Qing Yuan Liu

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.

Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China.